Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis: looking beyond BCG vaccines.

S Mustafa Abu1, R Al-Attiyah

  • 1Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. abusalim@hsc.kuniv.edu.kw

Journal of Postgraduate Medicine
|July 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody reactivity to <i>Mycobacterium tuberculosis</i>-specific regions of differences 1 and regions of differences 9 proteins and peptides in rabbits, mice, and humans.

International journal of mycobacteriology·2023
Same author

Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients.

Scandinavian journal of immunology·2012
Same author

Cellular immune responses in mice induced by M. tuberculosis PE35-DNA vaccine construct.

Scandinavian journal of immunology·2011
Same author

DNA vaccine constructs expressing Mycobacterium tuberculosis-specific genes induce immune responses.

Scandinavian journal of immunology·2010
Same author

Molecular cloning, expression, purification and immunological characterization of three low-molecular weight proteins encoded by genes in genomic regions of difference of mycobacterium tuberculosis.

Scandinavian journal of immunology·2010
Same author

Species-specific antigenic Mycobacterium tuberculosis proteins tested by delayed-type hypersensitivity response.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2010
Same journal

Assessment of exclusive breastfeeding practices in a tribal district of Maharashtra: A cross-sectional study.

Journal of postgraduate medicine·2026
Same journal

Leveraging immersive technology with virtual emulation for training of nonmedico combatants: A randomized controlled trial.

Journal of postgraduate medicine·2026
Same journal

From clinic to microscope: A study of clinicopathological concordance in 5000 skin biopsies from a tertiary care center.

Journal of postgraduate medicine·2026
Same journal

Early anticoagulation with warfarin for pulmonary embolism complicating active gastric ulcer: A case against guideline-mandated delay.

Journal of postgraduate medicine·2026
Same journal

Paradoxical Hemophagocytic Lymphohistiocytosis to Stevens-Johnson Syndrome - Toxic Epidermal Necrolysis- A rare immune phenomenon.

Journal of postgraduate medicine·2026
Same journal

Anesthetic management of neonate with hypoplastic left heart syndrome posted for exploratory laparotomy.

Journal of postgraduate medicine·2026
See all related articles

New tuberculosis (TB) vaccines targeting M. tuberculosis antigens like ESAT6 show promise in protecting mice. Further human trials are needed to confirm the safety and efficacy of these novel TB vaccine candidates.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Tuberculosis (TB) remains a major global health threat, causing millions of deaths annually.
  • Current BCG vaccines offer variable protection and pose risks to immunocompromised individuals, necessitating new vaccine development.
  • Comparative genome analysis identified M. tuberculosis-specific regions absent in BCG, highlighting potential targets for novel vaccines.

Purpose of the Study:

  • To investigate the immunogenicity and protective potential of M. tuberculosis-specific antigens, such as ESAT6, as vaccine candidates.
  • To evaluate the efficacy of ESAT6 and its derivatives, including fusion proteins and DNA vaccines, against M. tuberculosis infection in a mouse model.

Main Methods:

  • Comparative genome analysis of M. tuberculosis and BCG.

Related Experiment Videos

  • Identification and characterization of M. tuberculosis-specific antigens.
  • Immunization studies in mice using ESAT6, its peptide, ESAT6-antigen 85B fusion protein, and DNA vaccines.
  • Challenge studies with M. tuberculosis to assess vaccine efficacy.

    • Main Results:

    • ESAT6 and its peptide (aa51-70) demonstrated protective efficacy in mice challenged with M. tuberculosis.
    • Recombinant fusion of ESAT6 with M. tuberculosis antigen 85B enhanced protective efficacy.
    • DNA vaccine delivery of ESAT6 also conferred protection in the mouse model.

    Conclusions:

    • M. tuberculosis-specific antigens like ESAT6 represent promising candidates for developing new TB vaccines.
    • Different vaccine formulations, including fusion proteins and DNA vaccines, show potential for improved efficacy.
    • Safety and efficacy of these novel TB vaccines require validation through human clinical trials.